Medicare’s historic plan to slow prescription drug spending is taking shape.
Insurance
Posted inHealth Equity
One Doctor’s Crusade to Improve Health Literacy
Dr. Lisa Fitzpatrick believes plainspoken information from trusted messengers can help shrink health disparities, and some insurers are buying in.
Posted inPublic Health
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Posted inInsurance
Insuring America’s Long-Term Care Workforce
Joseph Benitez shares new research that assesses the impact of the ACA on insurance coverage for low-income nursing assistants.
Posted inPublic Health
Drugmakers and Patient Assistance Programs: Tricks or Treats?
Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.
Posted inInsurance
Medicare’s Prescription Drug Plan MakeoverÂ
An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Posted inInsurance
The Treacherous Transition from Medicaid to Private Insurance
Adrianna McIntyre shares new research on the effect of losing coverage through Medicaid and how long it takes to bounce back.
Posted inCost of Care
Lessons from a Trauma Center Boom in Texas
Sayeh Nikpay shares new research that examines the impact of a trauma center boom in Texas.
Posted inInsurance
4 Studies that Explain the Stakes of Medicare Open Enrollment
Leslie Walker shares four research studies to explain the stakes of Medicare open enrollment.
Posted inInsurance
The Push to End Cancer Screening Purgatory
Initial screenings for breast, lung and cervical cancer are free, but expensive secondary tests can leave patients in screening purgatory.